20250ACR_013997CHP INTRODUCED 2026-02-13 PASSED_ASSEMBLY 2026-03-12 PASSED_SENATE 2026-04-16 ENROLLED 2026-04-17 CHAPTERED 2026-04-21 FILED 2026-04-21 2025 ACR CHP CHR 0 Introduced by Assembly Member Calderon (Coauthors: Assembly Members Ortega, Addis, Aguiar-Curry, Ahrens, Alanis, Alvarez, Arambula, Ávila Farías, Bains, Bauer-Kahan, Bennett, Berman, Boerner, Bryan, Caloza, Carrillo, Chen, Connolly, Davies, DeMaio, Dixon, Elhawary, Ellis, Flora, Fong, Gabriel, Gallagher, Garcia, Gipson, Jeff Gonzalez, Mark González, Hadwick, Haney, Harabedian, Hart, Irwin, Jackson, Kalra, Lackey, Lee, Macedo, McKinnor, Muratsuchi, Nguyen, Pacheco, Papan, Patel, Patterson, Pellerin, Petrie-Norris, Ramos, Ransom, Rivas, Michelle Rodriguez, Rogers, Blanca Rubio, Sanchez, Schiavo, Schultz, Sharp-Collins, Solache, Soria, Stefani, Ta, Tangipa, Wallis, Ward, Wicks, Wilson, and Zbur) (Coauthors: Senators Alvarado-Gil and Valladares) LEAD_AUTHOR ASSEMBLY Calderon COAUTHOR ASSEMBLY Ortega COAUTHOR ASSEMBLY Addis COAUTHOR ASSEMBLY Aguiar-Curry COAUTHOR ASSEMBLY Ahrens COAUTHOR ASSEMBLY Alanis COAUTHOR ASSEMBLY Alvarez COAUTHOR ASSEMBLY Arambula COAUTHOR ASSEMBLY Ávila Farías COAUTHOR ASSEMBLY Bains COAUTHOR ASSEMBLY Bauer-Kahan COAUTHOR ASSEMBLY Bennett COAUTHOR ASSEMBLY Berman COAUTHOR ASSEMBLY Boerner COAUTHOR ASSEMBLY Bryan COAUTHOR ASSEMBLY Caloza COAUTHOR ASSEMBLY Carrillo COAUTHOR ASSEMBLY Chen COAUTHOR ASSEMBLY Connolly COAUTHOR ASSEMBLY Davies COAUTHOR ASSEMBLY DeMaio COAUTHOR ASSEMBLY Dixon COAUTHOR ASSEMBLY Elhawary COAUTHOR ASSEMBLY Ellis COAUTHOR ASSEMBLY Flora COAUTHOR ASSEMBLY Fong COAUTHOR ASSEMBLY Gabriel COAUTHOR ASSEMBLY Gallagher COAUTHOR ASSEMBLY Garcia COAUTHOR ASSEMBLY Gipson COAUTHOR ASSEMBLY Jeff Gonzalez COAUTHOR ASSEMBLY Mark González COAUTHOR ASSEMBLY Hadwick COAUTHOR ASSEMBLY Haney COAUTHOR ASSEMBLY Harabedian COAUTHOR ASSEMBLY Hart COAUTHOR ASSEMBLY Irwin COAUTHOR ASSEMBLY Jackson COAUTHOR ASSEMBLY Kalra COAUTHOR ASSEMBLY Lackey COAUTHOR ASSEMBLY Lee COAUTHOR ASSEMBLY Macedo COAUTHOR ASSEMBLY McKinnor COAUTHOR ASSEMBLY Muratsuchi COAUTHOR ASSEMBLY Nguyen COAUTHOR ASSEMBLY Pacheco COAUTHOR ASSEMBLY Papan COAUTHOR ASSEMBLY Patel COAUTHOR ASSEMBLY Patterson COAUTHOR ASSEMBLY Pellerin COAUTHOR ASSEMBLY Petrie-Norris COAUTHOR ASSEMBLY Ramos COAUTHOR ASSEMBLY Ransom COAUTHOR ASSEMBLY Rivas COAUTHOR ASSEMBLY Michelle Rodriguez COAUTHOR ASSEMBLY Rogers COAUTHOR ASSEMBLY Blanca Rubio COAUTHOR ASSEMBLY Sanchez COAUTHOR ASSEMBLY Schiavo COAUTHOR ASSEMBLY Schultz COAUTHOR ASSEMBLY Sharp-Collins COAUTHOR ASSEMBLY Solache COAUTHOR ASSEMBLY Soria COAUTHOR ASSEMBLY Stefani COAUTHOR ASSEMBLY Ta COAUTHOR ASSEMBLY Tangipa COAUTHOR ASSEMBLY Wallis COAUTHOR ASSEMBLY Ward COAUTHOR ASSEMBLY Wicks COAUTHOR ASSEMBLY Wilson COAUTHOR ASSEMBLY Zbur COAUTHOR SENATE Alvarado-Gil COAUTHOR SENATE Valladares Relative to Sleep Apnea Awareness Month.

Sleep Apnea Awareness Month Sleep Apnea Awareness Month. This measure would proclaim the month of March as Sleep Apnea Awareness Month in California. NO

WHEREAS, Obstructive sleep apnea (OSA) is a common, serious, and chronic sleep-related breathing disorder characterized by repeated interruptions of breathing during sleep, leading to fragmented sleep and reduced blood oxygen levels; and

WHEREAS, OSA affects an estimated to million adults in the United States, and leading sleep medicine experts estimate that up to percent of cases remain undiagnosed, leaving millions of individuals untreated and at an elevated risk for adverse health and safety outcomes; and

WHEREAS, Untreated OSA is associated with significant health risks, including hypertension, heart disease, stroke, type diabetes, obesity, depression, and increased all-cause mortality; and

WHEREAS, Evidence-based treatments for OSA, including continuous positive airway pressure, oral appliance therapy, weight management, and surgical interventions when appropriate, have been shown to improve daytime alertness, reduce blood pressure, and lower cardiovascular risk; and

WHEREAS, In addition to positive airway pressure therapy, oral appliance therapy is a clinically recognized and evidence-based treatment option for certain individuals with OSA; and

WHEREAS, Custom-fitted oral devices, including mandibular advancement devices and newer FDA-cleared oral appliance therapies and similar treatments, work by repositioning the jaw and airway structures during sleep to reduce airway collapse; and

WHEREAS, OSA poses substantial workforce and public safety risks due to excessive daytime sleepiness, impaired concentration, and reduced cognitive performance; and

WHEREAS, Research indicates that OSA disproportionately affects Latino, Black, Asian American, and Pacific Islander communities, and these populations are more likely to experience undiagnosed or untreated disease due to barriers to care; and

WHEREAS, Addressing disparities in sleep apnea awareness, screening, and treatment is essential to advancing health equity and improving health outcomes across California’s diverse population;

now, therefore,

be it Resolved, That the Assembly proclaims the month of March as Sleep Apnea Awareness Month in California; and be it further Resolved, That the Assembly recognizes OSA as a significant and underdiagnosed public health issue affecting individual health, workforce safety, and public safety; and be it further Resolved, That the Assembly affirms that advancing health equity in sleep apnea prevention, diagnosis, and treatment, particularly for Latino, Black, Asian American, and Pacific Islander communities, low-income, rural, and underserved communities, is critical to reducing preventable chronic disease and improving population health outcomes; and be it further Resolved by the Assembly of the State of California, the Senate thereof concurring, That the Chief Clerk of the Assembly transmit copies of this resolution to the author for appropriate distribution.